Market Insights
A biochip is a device that assimilates one or more laboratory tasks on a single chip to achieve high-throughput screening and automation. Advances in the field of nanotechnology have led to the development of lab-on-a-chip devices. In a few millimeters to a few square centimeters of chip size, lab-on-a-chip can integrate several laboratory functions.
The report titled “Global Lab-on-a-Chip Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” offers strategic insights into the overall lab-on-a-chip market, along with the market size and estimates for the duration of 2017–2025. The research study covers an in-depth analysis of market segments based on product type, application, and different geographical regions.
In order to help strategic decision-makers, the report also includes sections on the competitive profiling of the leading players in the global lab-on-a-chip market, attractive investment propositions, and market positioning of key manufacturers. Other in-depth analysis provided in the report includes:
Geographically, the global lab-on-a-chip market is studied for the following regional markets:
- North America
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa
The market size and forecast for these regional and country-level markets are presented in this study for the period 2015–2025. Market growth rates for the forecast period of 2015–2025 are also included in this report, considering 2016 as the base year.
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global lab-on-a-chip market. Tools such as key player market positioning and appealing investment propositions provide readers with insights into the global lab-on-a-chip market’s competitive scenario. This report concludes with a company profiles section that highlights major information about the key players engaged in the global lab-on-a-chip market. In-depth competitive environment analysis and historical year (2015) market size data are also provided in the report.
Thus, the research study provides a holistic view of the global lab-on-a-chip market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.
Based on the type of product, the lab-on-chip market is segmented into:
- DNA Microarrays
- Lab on a chip or microfluidics
- Protein Microarrays
- Tissue Biochips
- Carbohydrate Biochips
A biochip device is a device that assimilates one or more laboratory tasks on a single chip to achieve high-throughput screening and automation. Advances in the field of nanotechnology have led to the development of lab-on-a-chip devices. In a few millimeters to a few square centimeters of chip size, lab-on-a-chip can integrate several laboratory functions.
A biochip device is concerned with experiments carried out on a small scale, so it helps achieve high-throughput automation and screening. The lab-on-a-chip market is segmented into DNA microarrays, lab-on-a-chip/microfluidics, protein microarrays, tissue biochips, and carbohydrate biochips. Because of their widespread use in proteomics for better understanding of the human proteome, drug discovery, diagnostics, and personalized medicine, protein arrays led the overall product market.DNA microarrays are anticipated to grow at the fastest rate due to the growing demand for personalized medicines, target therapies, and the research and development of cancer therapies.
Based on the type of application, the lab-on-a-chip market is segmented into:
- Genomics and proteomics
- Diagnostics
- Drug Discovery
- Others
A lab-on-a-chip is a device that integrates one or more laboratory functions on a single integrated circuit or chip to achieve automation and high-throughput screening. The application of lab-on-a-chip is increasing in different fields of life sciences. From detecting breast cancer to screening for HIV and surviving serious diseases, all of it is done with the help of a chip or a microarray. LOC technology enables the use of small fluid volumes, which helps cut costs, the analysis of reagents, and response time. Several applications in life science and medicine have also been explored so far, including potential use in protein crystallization studies and DNA or RNA sequencing.
The applications studied in the global lab-on-a-chip market include genomics and proteomics, diagnostics, drug discovery, and others. The diagnostics segment held the largest share in the global lab-on-a-chip market by application. Early screening of breast cancer, HIV, and other infectious diseases is driving the market for the diagnostics segment. Genomics and proteomics are expected to grow at the highest rate due to rising research and development studies in genetics and sequencing that will drive the market in the future.
For the purpose of this study, the global lab-on-a-chip market is categorized into:
In the year 2016, North America emerged as the largest regional market for the lab-on-a-chip market. The highest market share of the region is attributed to the existence of an evolved healthcare and biotechnology research infrastructure, the availability of microarray chips at an affordable cost in the region, and the encouragement of diagnostic applications. Favorable private and public funding in research and development in the U.S. makes it the highest-grossing country in North America. Asia Pacific is anticipated to be the fastest-growing lab-on-a-chip market during the forecast period. Rapid entry of regional market leaders, unmet medical needs, and rising incidences of various infectious diseases would all serve as growth drivers for the Asia-Pacific lab-on-a-chip market. The competitors in the Asia Pacific market are budding and are continually working on introducing new clinical uses to augment the value of lab-on-a-chip technology.
